L09_NuclearImaging(1)

Nuclear imaging provides insight into the physiologic status of specific tissues or organs rather than detailed anatomical structures.
Focus on local uptake changes in dynamic studies (increased or reduced uptake) as well as atypical wash-in or wash-out rates.

Pharmacologic Agent:
- A substance selectively taken up by a targeted organ or biological compartment.
Radionuclide:
- Attached to the agent, producing high-energy photons (e.g., gamma-rays or 511 keV annihilation photons) capable of escaping the body.
Detection Device:
- Used to detect or image high-energy photons emitted during radioactive decay.

1920s: Introduction of radioactive isotopes for medical use.
1940s: Development of techniques for imaging radionuclide concentration in the human body.
1950s: Introduction of significant technologies including:
- Rectilinear scanner (Ben Cassen).
- Focusing multiporous collimator (Newell).
- The first true gamma camera (Hal Anger).
1970s: Advancements leading to the first positron emission tomography (PET) system.

Hal Anger: Inventor of the gamma camera; displayed at Geneva Atomic Energy Conference in 1963.
Michel M. Ter-Pogossian: Known as the "father of PET" for his contributions to the PET systems.

Tracer Injection: Introduction of a tracer molecule through intravenous injection, involved in metabolic processes.
Measurement: Concentration is assessed through emitted gamma rays which signal underlying biological activity.

Atom: Basic unit of matter with a nucleus (containing protons and neutrons) surrounded by electrons.
- Protons: Positively charged (1 amu).
- Neutrons: No charge (1 amu).
- Electrons: Negative charge (-1), negligible mass.
Isotopes: Variants of elements with the same proton number but different neutron counts.

Stable vs. Unstable Nuclei: Defined by their propensity to undergo radioactive decay.
- Radioactive elements decay over time to reach a more stable state.
Radiation emitted during decay includes various forms including gamma rays, which are biologically hazardous.

Nucleon Emission or Capture:
- Alpha Decay: Emission of an alpha particle (consisting of 2 protons and 2 neutrons).
- Beta Decay: Emission of beta particles from neutron transformations.
- Electron Capture: Process where a nucleus absorbs an orbital electron converting a proton into a neutron.
Gamma-ray Emissions:
- Released following nuclear transformation.
- Key for tracing biological activity since they possess high penetration ability.

Gamma Cameras: Utilize sensitive detectors to interact with emitted gamma rays, employing collimation to restrict detection angles.
- Resolution depends on the design and collimation which impacts sensitivity and imaging accuracy.

PET exploits the annihilation of positrons emitted from certain radionuclides (e.g., fluorine-18) used in cancer imaging, providing quantitative data through simultaneous detection of twin photons.
Hybrid PET/CT Systems: Merge functional and anatomical imaging, enhancing diagnostic accuracy and reducing scan time.

Tumor Imaging: Detects and monitors cancers through metabolic activity evaluation (e.g., FDG uptake in glucose metabolism).
Cardiovascular Imaging: Evaluates myocardial function and detects conditions like ischemia or infarction using specific radiopharmaceuticals.
Neurological Disorders: Assists in the diagnosis and monitoring of conditions such as Parkinson's disease through imaging dopamine pathways.

For Patients: Awareness of radiation exposure, tracer distribution in the body, and biological excretion.
For Healthcare Providers: Radiation safety measures, maintaining distance from sources, and managing exposure through precautionary measures.